Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Stock Market
Government
Executive Activities
Banking
Corporate Performance
Economic News
International and US Foreign Trade
Aerospace & Defense
Commodities & Futures
Table bottom

Migraines
In the news release, HeartStitch® "Sutures The Future" at the TCT in Denver, Colorado, issued 20-Nov-2017 by Nobles Medical Technology II, Inc. over PR Newswire, we are advised by the company that the HeartStitch® Inc. boilerplate and logo...
PR Newswire, 4:13pm ET



PALM BEACH, Florida, November 20, 2017 /PRNewswire/ -- A new study conducted by researchers at the University of New Mexico, involving medical cannabis and prescription opioid use among chronic pain patients, found a distinct connection...
PR Newswire Europe, 8:38am ET

A new study conducted by researchers at the University of New Mexico, involving medical cannabis and prescription opioid use among chronic pain patients, found a distinct connection between having the legal ability to use cannabis and significant...
PR Newswire, 8:38am ET

Research Desk Line-up: Immunomedics Post Earnings Coverage LONDON, UK / ACCESSWIRE / November 20, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Biohaven Pharmaceutical Holding Co....
ACCESSWIRE, 7:48am ET

TCT 2017 in Denver, Colorado, provided a forum for Interventional Cardiologists from around the world to discover the HeartStitch® Suture-Based Solutions to Structural Heart Procedures. These key procedures of interest include septal repair,...
PR Newswire, 6:23am ET

Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), ("Veritas" or the "Company") announces that its research arm, Cannevert Therapeutics Ltd. ("CTL") has signed a letter of intent with the Fundacion de Investigacion (FDI) in San Juan,...
GlobeNewswire, 3:13am ET

1-6 of 6


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.